Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (15)

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Giant cell arteritis: Is the clinical spectrum of the disease changing?

    BMC Geriatrics, Vol. 19, Núm. 1

  3. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2016

  1. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

    Clinical and Experimental Rheumatology

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  2. Tocilizumab in refractory aortitis: A study on 16 patients and literature review

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

2012

  1. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

    Arthritis Research and Therapy, Vol. 14, Núm. 3

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

  3. Influence of the IL6 gene in susceptibility to systemic sclerosis

    Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302

2010

  1. Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 1, pp. 131-135

  2. Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1502-1504

  3. Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis

    Human Immunology, Vol. 71, Núm. 5, pp. 525-529

2009

  1. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 36, Núm. 5, pp. 1021-1025